Speaker illustration

Mr Aaram Omar Khader

Erasmus University Rotterdam, Rotterdam (Netherlands (The))

Member of:

European Society of Cardiology
Heart Failure Association

Prevalence of reaching target low-density lipoprotein cholesterol (LDL-C) in very high-risk patients using high intensity lipid-modifying therapy.

Event: ESC Congress 2022

Topic: Prevention

Session: Predicting risks

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb